tradingkey.logo

Abbott Receives Regulatory Approval For The First Denosumab Biosimilar In Thailand

ReutersAug 26, 2025 6:11 AM

- Abbott Laboratories ABT.N:

  • ABBOTT RECEIVES REGULATORY APPROVAL FOR THE FIRST DENOSUMAB BIOSIMILAR IN THAILAND, EXPANDING ACCESS TO BONE DISEASE TREATMENT

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI